Free Alerts   Login
Health Care › Services-Commercial Physical & Biological Research

MXCT Stock Price Correlated With MaxCyte Financials

MXCT Stock Price vs. Quarterly
MXCT
Income Statement
Cash Flow
Balance Sheet

MXCT Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

MXCT Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

MXCT Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock.
7,341,386 sh
453,390 sh
7%
$34,504
$13,013
Cadian Capital Management, Lp
5,644,898 sh
5,644,898 sh
NEW
$26,531
$26,531
Vanguard Group
5,282,108 sh
243,261 sh
5%
$24,826
$9,105
Vitruvian Partners
5,043,356 sh
 
$23,704
Millennium Management
5,012,283 sh
1,165,642 sh
30%
$23,558
$11,556
Morgan Stanley
3,481,010 sh
2,155,840 sh
163%
$16,360
$12,226
FMR
2,833,715 sh
2,831,312 sh
117824%
$13,318
$13,311
Portolan Capital Management
2,757,249 sh
613,583 sh
29%
$12,959
$6,271
Massachusetts Financial Services /Ma/
2,537,114 sh
584,372 sh
30%
$11,924
$5,831
Geode Capital Management
2,096,497 sh
123,060 sh
6%
$9,855
$3,697
State Street
1,943,997 sh
103,823 sh
6%
$9,137
$3,396
Blue Water Life Science Advisors
1,885,000 sh
 
$8,860
Mudita Advisors LLP
1,881,349 sh
1,218,696 sh
184%
$8,842
$5,562
River & Mercantile Asset Management Llp
1,518,646 sh
45,392 sh
3%
$7,053
$2,465
Ameriprise Financial
1,448,907 sh
139,629 sh
11%
$6,809
$2,724
Granahan Investment Management/Ma
1,428,449 sh
-547,398 sh
-28%
$6,714
$549
Arrowmark Colorado Holdings
1,373,777 sh
-1,035,261 sh
-43%
$6,457
-$1,059
Northernrp
795,086 sh
-2,467 sh
0%
$3,737
$1,248
Dimensional Fund Advisors
694,961 sh
218,356 sh
46%
$3,266
$1,778
Silvercrest Asset Management Group
668,880 sh
-591,743 sh
-47%
$3,144
-$789

Free historical financial statements for MaxCyte Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 11 quarters since 2021. Compare with MXCT stock chart to see long term trends.

Data imported from MaxCyte Inc. SEC filings. Check original filings before making any investment decision.